T2 Biosystems Inc Enterprise value
What is the Enterprise value of T2 Biosystems Inc?
The Enterprise value of T2 Biosystems Inc is $76.25M
What is the definition of Enterprise value?
Enterprise value is a measure of a company’s total market value. It is calculated as market capitalization with debt, minority interest, and preferred shares minus total cash and cash equivalents.
ttm (trailing twelve months)
It is a sum of claims by all claimants including creditors (secured and unsecured) and shareholders (preferred and common). Enterprise value is one of the fundamental metrics used in business valuation, financial modeling, accounting, portfolio analysis, and risk analysis. Enterprise value is more comprehensive than market capitalization, which only reflects common equity and is considered more representative of a company’s value. Enterprise value reflects the opportunistic nature of business and may change substantially over time because of both external and internal conditions.
Enterprise value can be negative if the company holds abnormally high amounts of cash that is not reflected in the market value of the stock and total capitalization. Cash is subtracted in the calculation because it reduces the net cost to a potential purchaser. The effect applies whether the cash is used to issue dividends or to pay down debt. Value of minority interest is added because it reflects the claim on assets consolidated into the firm in question. Value of associate companies is subtracted because it reflects the claim on assets consolidated into other firms. EV should also include such special components as unfunded pension liabilities, employee stock options, environmental provisions, abandonment provisions, and so on, since they also reflect claims on the company.
Enterprise value of companies in the Health Care sector on NASDAQ compared to T2 Biosystems Inc
What does T2 Biosystems Inc do?
t2 biosystems is developing innovative diagnostic products to improve patient health. with two fda-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, t2 biosystems is an emerging leader in the field of in vitro diagnostics. our initial development efforts target sepsis, hemostasis, bacteria and lyme disease, which are areas of significant unmet medical need. the company is utilizing its proprietary t2 magnetic resonance platform, or t2mr®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. at t2 biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. we invite you to apply for one of our open positions at www
Companies with enterprise value similar to T2 Biosystems Inc
- Titan Mining has Enterprise value of $75.95M
- Image Resources NL has Enterprise value of $76.04M
- Gordon Pointe Acquisition has Enterprise value of $76.04M
- Wanda Hotel Development has Enterprise value of $76.05M
- Commercial Syn Bags has Enterprise value of $76.05M
- Blue has Enterprise value of $76.17M
- T2 Biosystems Inc has Enterprise value of $76.25M
- Urja Global has Enterprise value of $76.25M
- Fluence has Enterprise value of $76.31M
- ATTRAQT plc has Enterprise value of $76.32M
- Bragg Gaming has Enterprise value of $76.38M
- Great Panther Mining has Enterprise value of $76.41M
- Anaconda Mining has Enterprise value of $76.42M